These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18438125)

  • 1. Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
    Isenberg JS; Romeo MJ; Maxhimer JB; Smedley J; Frazier WA; Roberts DD
    Ann Surg; 2008 May; 247(5):860-8. PubMed ID: 18438125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
    Isenberg JS; Shiva S; Gladwin M
    Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.
    Maxhimer JB; Shih HB; Isenberg JS; Miller TW; Roberts DD
    Plast Reconstr Surg; 2009 Dec; 124(6):1880-1889. PubMed ID: 19952644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
    Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
    Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.
    Csányi G; Yao M; Rodríguez AI; Al Ghouleh I; Sharifi-Sanjani M; Frazziano G; Huang X; Kelley EE; Isenberg JS; Pagano PJ
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2966-73. PubMed ID: 23087362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing survival of ischemic tissue by targeting CD47.
    Isenberg JS; Romeo MJ; Abu-Asab M; Tsokos M; Oldenborg A; Pappan L; Wink DA; Frazier WA; Roberts DD
    Circ Res; 2007 Mar; 100(5):712-20. PubMed ID: 17293482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
    Rogers NM; Roberts DD; Isenberg JS
    Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
    Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.
    Rogers NM; Sharifi-Sanjani M; Yao M; Ghimire K; Bienes-Martinez R; Mutchler SM; Knupp HE; Baust J; Novelli EM; Ross M; St Croix C; Kutten JC; Czajka CA; Sembrat JC; Rojas M; Labrousse-Arias D; Bachman TN; Vanderpool RR; Zuckerbraun BS; Champion HC; Mora AL; Straub AC; Bilonick RA; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2017 Jan; 113(1):15-29. PubMed ID: 27742621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.
    Julovi SM; Sanganeria B; Minhas N; Ghimire K; Nankivell B; Rogers NM
    Lab Invest; 2020 Sep; 100(9):1184-1196. PubMed ID: 32366943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
    Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
    Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.
    Isenberg JS; Maxhimer JB; Powers P; Tsokos M; Frazier WA; Roberts DD
    Surgery; 2008 Nov; 144(5):752-61. PubMed ID: 19081017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
    Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
    J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1, CD47, and SIRPα display cell-specific molecular signatures in human islets and pancreata.
    Erdem N; Chen KT; Qi M; Zhao Y; Wu X; Garcia I; Ku HT; Montero E; Al-Abdullah IH; Kandeel F; Roep BO; Isenberg JS
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E347-E357. PubMed ID: 36791324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
    Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
    Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
    Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.
    Rogers NM; Sharifi-Sanjani M; Csányi G; Pagano PJ; Isenberg JS
    Matrix Biol; 2014 Jul; 37():92-101. PubMed ID: 24418252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis.
    Singla B; Aithbathula RV; Pervaiz N; Kathuria I; Swanson M; Ekuban FA; Ahn W; Park F; Gyamfi M; Cherian-Shaw M; Singh UP; Kumar S
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1234-1250. PubMed ID: 37259865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
    Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
    J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
    Isenberg JS; Maxhimer JB; Hyodo F; Pendrak ML; Ridnour LA; DeGraff WG; Tsokos M; Wink DA; Roberts DD
    Am J Pathol; 2008 Oct; 173(4):1100-12. PubMed ID: 18787106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.